https://doi.org/10.4081/reumatismo.2014.799
Why golimumab in the treatment of psoriatic arthritis, ankylosing spondylitis and rheumatoid arthritis?
Submitted: 12 October 2014
Accepted: 22 December 2014
Published: 31 March 2015
Accepted: 22 December 2014
Abstract Views: 2338
PDF: 2189
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
How to Cite
Rossini, M., Viapiana, O., Orsolini, G., Fracassi, E., Idolazzi, L., Gatti, D., … Govoni, M. (2015). Why golimumab in the treatment of psoriatic arthritis, ankylosing spondylitis and rheumatoid arthritis?. Reumatismo, 66(4), 285–303. https://doi.org/10.4081/reumatismo.2014.799
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
Similar Articles
- M. Benucci, A. Damiani, F. Li Gobbi, V. Grossi, M. Infantino, A. Arena, M. Manfredi, Jaccoud’s arthropathy, an unusual manifestation of idiopathic retroperitoneal fibrosis: rapid improvement of symptoms after tocilizumab treatment , Reumatismo: Vol. 69 No. 2 (2017)
- A.M. Elsaman, A. Sayed, A.R. Radwan, Hand dominance in early and established rheumatoid arthritis: evaluation by dynamometer, Ritchie index and musculoskeletal ultrasound: a cross sectional study , Reumatismo: Vol. 72 No. 3 (2020)
- F. Ingegnoli, N. Del Papa, E. Lupi, D.P. Comina, W. Maglione, V. Gerloni, F. Fantini, Anti-chromatin antibodies in juvenile rheumatoid arthritis , Reumatismo: Vol. 55 No. 4 (2003)
- S. Parisi, A. Bortoluzzi, G.D. Sebastiani, F. Conti, R. Caporali, N. Ughi, I. Prevete, A. Ariani, M. Manara, G. Carrara, C.A. Scirè, The Italian Society for Rheumatology clinical practice guidelines for rheumatoid arthritis , Reumatismo: Vol. 71 No. S1 (2019)
- U. Fiocco, M. Vezzù, L. Cozzi, S. Todesco, IL-1Ra (recombinant human IL-1 receptor antagonist) in the treatment of rheumatoid arthritis: the efficacy , Reumatismo: Vol. 56 No. s1 (2004)
- G. Brambilla, A. Brucato, Y. Adler, M. Bosetti, P. Coppini, A. Caforio, D. Spodick, B. Canesi, Recurrent acute idiopathic pericarditis: rheumatologic therapy, autoantibodies and long term outcome , Reumatismo: Vol. 59 No. 1 (2007)
- M. Filippini, C. Bazzani, S. Zingarelli, T. Ziglioli, M. Nuzzo, M. Vianelli, C. Biasini Rebaioli, R. Cattaneo, R. Gorla, Anti-TNFα agents in elderly patients with rheumatoid arthritis: a study of a group of 105 over sixty five years old patients , Reumatismo: Vol. 60 No. 1 (2008)
- R. Herrera-Esparza, E. Avalos-Diaz, Infliximab treatment in a case of rheumatoid scleromalacia perforans , Reumatismo: Vol. 61 No. 3 (2009)
- M. Gutierrez, A. Becciolini, C. Bertolazzi, L. Di Geso, M. Tardella, A. Ariani, E. Filippucci, W. Grassi, Polyarthritis flare in patient with ankylosing spondylitis treated with infliximab , Reumatismo: Vol. 62 No. 3 (2010)
- A. Cauli, G. Dessole, P.P. Nurchis, A. Vacca, A. Mameli, P. Garau, R. Pala, G. Passiu, A. Mathieu, The role of HLA-B27 molecules in the pathogenesis of ankylosing spondylitis , Reumatismo: Vol. 54 No. 3 (2002)
<< < 18 19 20 21 22 23 24 25 26 27 > >>
You may also start an advanced similarity search for this article.
